Total Payments
$4,099
2024 Payments
$75.54
Companies
22
Transactions
345
Medicare Patients
9,091
Medicare Billing
$989,499
Payment Breakdown by Category
Food & Beverage$4,089 (99.8%)
Education$10.00 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,089 | 343 | 99.8% |
| Education | $10.00 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $593.68 | 37 | $0 (2024) |
| GlaxoSmithKline, LLC. | $500.93 | 38 | $0 (2023) |
| PFIZER INC. | $470.91 | 47 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $395.55 | 42 | $0 (2019) |
| Novo Nordisk Inc | $363.78 | 27 | $0 (2020) |
| Amgen Inc. | $205.50 | 13 | $0 (2020) |
| Mylan Specialty L.P. | $200.25 | 18 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $165.00 | 15 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $160.66 | 11 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $158.80 | 27 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $75.54 | 4 | AstraZeneca Pharmaceuticals LP ($75.54) |
| 2023 | $38.23 | 2 | AstraZeneca Pharmaceuticals LP ($22.83) |
| 2022 | $17.21 | 1 | AstraZeneca Pharmaceuticals LP ($17.21) |
| 2020 | $258.08 | 18 | AstraZeneca Pharmaceuticals LP ($59.70) |
| 2019 | $1,156 | 93 | GlaxoSmithKline, LLC. ($150.41) |
| 2018 | $1,364 | 117 | GlaxoSmithKline, LLC. ($178.66) |
| 2017 | $1,189 | 110 | AstraZeneca Pharmaceuticals LP ($232.23) |
All Payment Transactions
345 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Respiratory | ||||||
| 08/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Respiratory | ||||||
| 06/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Respiratory | ||||||
| 02/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Respiratory | ||||||
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Respiratory | ||||||
| 09/09/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: RESPIRATORY | ||||||
| 09/29/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Respiratory | ||||||
| 06/23/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Respiratory | ||||||
| 05/11/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Respiratory | ||||||
| 04/08/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Endocrinology | ||||||
| 04/06/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Diabetes | ||||||
| 03/10/2020 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: Diabetes | ||||||
| 03/09/2020 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: NEUROSCIENCE | ||||||
| 03/04/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/03/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: RESPIRATORY | ||||||
| 02/28/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: NEUROSCIENCE | ||||||
| 02/25/2020 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Neuroscience | ||||||
| 02/19/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: Respiratory | ||||||
| 02/07/2020 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Neuroscience | ||||||
| 02/04/2020 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: Respiratory | ||||||
| 01/31/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: RESPIRATORY | ||||||
| 01/28/2020 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Neuroscience | ||||||
| 01/27/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Endocrinology | ||||||
| 01/24/2020 | Mylan Specialty L.P. | Yupelri (Drug), Perforomist | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Respiratory and Allergy | ||||||
| 01/14/2020 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,945 | 3,647 | $511,378 | $192,904 |
| 2022 | 31 | 2,327 | 4,196 | $651,248 | $257,491 |
| 2021 | 29 | 2,339 | 4,472 | $687,821 | $270,337 |
| 2020 | 33 | 2,480 | 4,837 | $752,347 | $268,766 |
Total Patients
9,091
Total Services
17,152
Medicare Billing
$989,499
Procedure Codes
120
All Medicare Procedures & Services
120 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 371 | 1,064 | $188,328 | $61,993 | 32.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 282 | 282 | $71,628 | $33,922 | 47.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 281 | 434 | $108,934 | $32,750 | 30.1% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2023 | 73 | 87 | $24,795 | $12,161 | 49.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 30 | 30 | $12,780 | $8,136 | 63.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 29 | 31 | $16,833 | $6,349 | 37.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 83 | 83 | $8,715 | $5,967 | 68.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 31 | 78 | $13,806 | $4,243 | 30.7% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 28 | 28 | $5,600 | $3,662 | 65.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 131 | 366 | $6,954 | $3,446 | 49.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 120 | 120 | $4,080 | $3,442 | 84.4% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 39 | 97 | $7,857 | $2,661 | 33.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 25 | $8,775 | $2,384 | 27.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $4,550 | $2,151 | 47.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 44 | 51 | $5,202 | $1,928 | 37.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 56 | 57 | $1,881 | $1,635 | 86.9% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 37 | 109 | $2,725 | $1,309 | 48.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 11 | 16 | $3,984 | $1,293 | 32.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 60 | 139 | $6,811 | $1,195 | 17.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 40 | 40 | $1,280 | $854.10 | 66.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 11 | 11 | $1,463 | $381.32 | 26.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 44 | 45 | $2,340 | $315.51 | 13.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 40 | 324 | $648.00 | $244.06 | 37.7% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 11 | 11 | $396.00 | $194.59 | 49.1% |
| 90471 | Administration of vaccine | Office | 2023 | 15 | 15 | $600.00 | $161.26 | 26.9% |
About Dr. Samantha Moery, D.O
Dr. Samantha Moery, D.O is a Family Medicine healthcare provider based in Enid, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1578611935.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samantha Moery, D.O has received a total of $4,099 in payments from pharmaceutical and medical device companies, with $75.54 received in 2024. These payments were reported across 345 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($4,089).
As a Medicare-enrolled provider, Moery has provided services to 9,091 Medicare beneficiaries, totaling 17,152 services with total Medicare billing of $989,499. Data is available for 4 years (2020–2023), covering 120 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Enid, OK
- Active Since 01/08/2007
- Last Updated 08/19/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1578611935
Products in Payments
- XIFAXAN (Drug) $314.66
- TRELEGY ELLIPTA (Drug) $207.66
- FARXIGA (Drug) $206.42
- XARELTO (Drug) $165.00
- BROVANA (Drug) $164.84
- Aimovig (Biological) $149.37
- CHANTIX (Drug) $141.48
- Yupelri (Drug) $139.73
- ANORO (Drug) $130.83
- ELIQUIS (Drug) $125.15
- BYDUREON (Drug) $120.08
- EUCRISA (Drug) $116.09
- BREZTRI (Drug) $115.58
- JANUVIA (Drug) $114.82
- Tresiba (Drug) $114.11
- SYMBICORT (Drug) $109.83
- Victoza (Drug) $107.24
- UTIBRON (Drug) $92.09
- Ozempic (Drug) $83.79
- TOUJEO (Drug) $76.23
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Enid
Renah Gibson, Do, DO
Family Medicine — Payments: $6,775
Family Medicine $6,775
Charles Jantzen, Do, DO
Family Medicine — Payments: $5,706
Family Medicine $5,706
Dr. Robi Chatterji, M.d, M.D
Family Medicine — Payments: $5,394
Family Medicine $5,394
Jonathan Bushman, Do, DO
Family Medicine — Payments: $4,277
Family Medicine $4,277
Dr. Richard Rivers, Md, MD
Family Medicine — Payments: $3,367
Family Medicine $3,367
Dr. Barbara Whinery, Md, MD
Family Medicine — Payments: $2,686
Family Medicine $2,686